Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Biochem Pharmacol. 2007 Mar 24;73(12):1947–1956. doi: 10.1016/j.bcp.2007.03.022

Table 2.

Modified DNA base content in MCF-10A cells cultured for up to 96 hours with 0.1 μM doxorubicin

DNA base 0 h 24 h 48 h 72 h 96 h
5OH-5-MeHyd 1 1.72±0.44 2.24±0.88 2.24±0.49* 2.45±0.10*
5-OH-Hyd 1 1.58±0.45 1.94±0.72 2.14±0.59 2.36±0.50*
5-OH-Ura 1 1.36±0.29 1.82±0.27* 2.21±0.30* 2.21±0.20*
5-OH-Cyt 1 1.29±0.3 1.34±0.08* 1.88±0.25* 1.56±0.24
Thy Gly 1 1.48±0.31 1.14±0.19 2.00±0.09* 3.08±1.39
5,6diOH-Ura 1 1.63±0.36 1.65±0.26 2.22±0.48* 1.73±0.06*
FapyAde 1 1.28±0.17 1.44±0.43 1.65±0.45 1.46±0.31
8-OH-Ade 1 1.55±0.41 1.69±0.26* 2.10±0.43* 1.87±0.40
Xan 1 1.71±0.43 2.05±0.10* 2.48±0.80 2.59±0.74
2-OH-Ade 1 1.49±0.09* 1.34±0.36 1.84±0.55 2.15±0.37*
FapyGua 1 1.33±0.12* 1.23±0.22 1.68±0.20* 2.27±0.62*
8-OH-Gua 1 1.10±0.29 1.11±0.22 1.80±0.16* 1.96±0.45
*

P < 0.05 versus control DNA.